Sugi Predict

Sugi Predict / Compounds / SCHEMBL1242540

SCHEMBL1242540

SCHEMBL1242540

CCCCCOc1ccc(-c2ccc(OC(F)(F)F)cc2)cc1N(Cc1ccccc1)C(=O)C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINE1 P05121 4/20 0.50
▸ PDE4A P27815 2/20 0.40
▸ PDE4B Q07343 2/20 0.40
▸ PDE4C Q08493 2/20 0.40
▸ PDE4D Q08499 2/20 0.40
▸ NR1H4 Q96RI1 1/20 0.40
▸ LTB4R2 Q9NPC1 4/20 0.39
▸ PTPN11 Q06124 3/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ PTPN6 P29350 1/20 0.39
▸ MRGPRX4 Q96LA9 1/20 0.38
▸ MCHR1 Q99705 1/20 0.38
▸ HDAC3 O15379 2/20 0.37
▸ HDAC4 P56524 2/20 0.37
▸ HDAC1 Q13547 2/20 0.37
▸ HDAC7 Q8WUI4 2/20 0.37
▸ HDAC2 Q92769 2/20 0.37
▸ HDAC10 Q969S8 2/20 0.37
▸ HDAC11 Q96DB2 2/20 0.37
▸ HDAC8 Q9BY41 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242413 0.92 SERPINE1 (0.60) SERPINE1LTB4R2PTPN11PTPN1PTPN6
SCHEMBL1241544 0.91 NR1H4 (0.41) SERPINE1NR1H4LTB4R2PTPN11PTPN1
SCHEMBL13581023 0.90 PDE4A (0.44) SERPINE1PDE4APDE4BPDE4CPDE4D
SCHEMBL15434080 0.90 PDE4A (0.44) SERPINE1PDE4APDE4BPDE4CPDE4D
SCHEMBL13580898 0.89 PDE4A (0.43) SERPINE1PDE4APDE4BPDE4CPDE4D
SCHEMBL1241446 0.89 NR1H4 (0.42) SERPINE1NR1H4LTB4R2MCHR1PPARD
SCHEMBL13580904 0.89 SERPINE1 (0.45) SERPINE1PDE4APDE4BPDE4CPDE4D
SCHEMBL12890146 0.88 SERPINE1 (0.56) SERPINE1NR1H4MRGPRX4MCHR1PPARD
SCHEMBL13581246 0.87 PPARD (0.39) SERPINE1MCHR1HDAC3HDAC4HDAC1
SCHEMBL12953341 0.87 PDE4A (0.47) SERPINE1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884234-B2 N-[4-(tert-butyl)benzyl]-N-[4 -(trifluoromethoxy)biphenyl-3-yl]oxamic Acid; Inhibitors of plasminogen activator inhibitor-1 (PAI-1); thrombogenesis, fibrogenesis, accumulation of visceral fat, cell proliferation, angiogenesis INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2011-02-08 — — US disclosed
US-20090215899-A9 N-Phenyloxamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-08-27 — — US disclosed
EP-2072498-A1 N-PHENYLOXAMIDIC ACID DERIVATIVE Institute of Medicinal Molecular Design, Inc. (JP) 2009-06-24 — — EP disclosed
US-20080249175-A1 N-Phenyloxamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2008-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249175-A1 N-Phenyloxamide derivatives SERPINE1, SERPINH1, F12 SERPINE1 1/4885PDE4A 3696/4885PDE4B 4220/4885
US-20090215899-A9 N-Phenyloxamide derivatives SERPINE1, SERPINH1, F12 SERPINE1 1/4885PDE4A 3696/4885PDE4B 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.